Individual Management Manufacturing Specialization 
Minnesota Academy of Family Physicians
MARCH 27, 2025
The Minnesota Hospital Association, as well as some individual hospitals, testified in support of the bill. The bill addresses Medicare supplement policies and individual health plans , including: Allowing Medicare supplement policies to factor in late enrollment and reenrollment when determining premiums. Read a summary of S.F.
Imperial Center Family Medicine
JUNE 2, 2025
The liver manufactures new cholesterol molecules and captures excess from circulation for excretion. To eliminate excess cholesterol, specialized liver enzymes transform it into bile salts that get stored in your gallbladder. LDL and HDL are two famous examples, carrying cargo to and from tissues and blood vessels as needed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Medical Futurist
JUNE 21, 2025
Although this revolution has been brewing for years, the past few months marked a major change , as algorithms finally moved out of the specialized labs and into our daily lives. The situation today is as follows: One company manufactures software for the radiology department which use a certain format of AI in their daily work.
FDA Law
FEBRUARY 13, 2025
In fact, eSTAR does not allow a PCCP to be included in a Special 510(k); attempting to do so results in the message if you are establishing a PCCP this should not be done in a Special 510(k). Manufacturers should develop the Modification Protocol consistent with their quality system and should follow their risk management processes.
FDA Law
MAY 8, 2023
The discussion paper described a PCCP as including (1) the types of anticipated modifications (SaMD Pre-Specifications or SPS) based on the retraining and model update strategy and (2) the associated methodology (Algorithm Change Protocol or ACP) being used to implement those changes in a controlled manner to manage patient risks.
FDA Law
MAY 19, 2023
In this blog we examine the Special Controls put in place to mitigate false results, incorrect interpretation of results, and incorrect operation of the device. The Special Controls are silent on what would constitute appropriate levels of evidence necessary to satisfy this criterion. analytical, clinical and stability).
FDA Law
MAY 20, 2021
We are providing a post in three parts on cyclic and on-site inspections in which we focus on the background of inspections, how investigators conduct them, and how registrants should proactively prepare for and manage them. The policies and procedures should include a section on how the registrant handles DEA inspections.
Expert insights. Personalized for you.
52 
Let's personalize your content